These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8082582)

  • 1. 32P-postlabeling methods for DNA adduct detection: overview and critical evaluation.
    Randerath K; Randerath E
    Drug Metab Rev; 1994; 26(1-2):67-85. PubMed ID: 8082582
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for testing compounds for DNA adduct formation.
    Reddy MV
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA dosimetry following carcinogen exposure using accelerator mass spectrometry and 32P-postlabeling.
    Felton JS; Turteltaub KW; Gledhill BL; Vogel JS; Buonarati MH; Davis JC
    Prog Clin Biol Res; 1991; 372():243-53. PubMed ID: 1956922
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural and endogenous DNA adducts as detected by 32P-postlabeling.
    Gupta RC; Spencer-Beach G
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):14-21. PubMed ID: 8628914
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved 32P-postlabelling assay for detection and quantitation of styrene 7,8-oxide-DNA adducts.
    Cantoreggi S; Gupta RC; Lutz WK
    IARC Sci Publ; 1993; (124):201-5. PubMed ID: 8225485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA adduct determination in humans.
    Poirier MC; Weston A
    Prog Clin Biol Res; 1991; 372():205-18. PubMed ID: 1956919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adducts of nitropolycyclic aromatic hydrocarbons.
    Beland FA; Marques MM
    IARC Sci Publ; 1994; (125):229-44. PubMed ID: 7806315
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA adducts of allyl compounds, enals and unsaturated ketones. Significance for mutagenicity and carcinogenicity.
    Eder E; Sebeikat D; Zugelder JP; Hoffman C; Bastian H; Deininger C; Scheckenbach S
    IARC Sci Publ; 1994; (125):443-7. PubMed ID: 7806336
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative aspects of 32P-postlabeling.
    Hemminki K; Szyfter K; Vodicka P; Koivisto P; Mustonen R; Reunanen A
    Prog Clin Biol Res; 1991; 372():219-28. PubMed ID: 1956920
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues.
    Nath RG; Ocando JE; Chung FL
    Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabeling of DNA adducts arising from complex mixtures: HPLC versus TLC separation applied to adducts from petroleum products.
    Eriksson HL; Zeisig M; Ekström LG; Möller L
    Arch Toxicol; 2004 Mar; 78(3):174-81. PubMed ID: 14652713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adducts of lactones, sultones, acylating agents and acrylic compounds.
    Solomon JJ
    IARC Sci Publ; 1994; (125):179-98. PubMed ID: 7806312
    [No Abstract]   [Full Text] [Related]  

  • 20. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.